GW Pharmaceuticals plc (Nasdaq: GWPH) stock was down about 4% in the extended hours of trading after the company missed analyst estimates
Categories
biopharma
Earnings preview: GW Pharmaceuticals’ cannabis-based drug to play a major role in the future
The UK-based GW Pharmaceuticals (Nasdaq: GWPH) is set to report its fourth quarter and fiscal 2018-end results for the period ending September